Long-term outcome after haploidentical stem cell transplantation in children

Aversa, 1998, Mismatched T cell-depleted hematopoietic stem cell transplantation for children with high-risk acute leukemia, Bone Marrow Transplant., 22, S29 Handgretinger, 2001, Megadose transplantation of purified peripheral blood CD34+ progenitor cells from HLA-mismatched parental donors in children, Bone Marrow Transplant., 27, 777, 10.1038/sj.bmt.1702996 Lang, 2004, Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases, Bone Marrow Transplant., 33, 25, 10.1038/sj.bmt.1704303 Aversa, 2001, Haploidentical stem cell transplantation in leukemia, Blood Rev., 15, 111, 10.1054/blre.2001.0157 Handgretinger, 2003, Megadose transplantation of highly purified haploidentical stem cells: current results and future prospects, Pediatr. Transplant., 7, 51, 10.1034/j.1399-3046.7.s3.7.x Klingebiel, 2004, Haploidentical transplantation for acute lymphoblastic leukemia in childhood, Blood Rev., 18, 181, 10.1016/S0268-960X(03)00063-8 Lang, 2004, Transplantation of a combination of CD133(+) and CD34(+) selected progenitor cells from alternative donors, Br. J. Haematol., 124, 72, 10.1046/j.1365-2141.2003.04747.x Bader, 2004, Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?, J. Clin. Oncol., 22, 1696, 10.1200/JCO.2004.05.198 Greil, 2004, Prophylactic use of ribavirin in combination with preemptive cidofovir treatment protects paediatric stem cell transplant recipients from life-threatening adenovirus infection, Bone Marrow Transplant., 33, S42 Lang, 1999, Clinical scale isolation of highly purified peripheral CD34(+) progenitors for autologous and allogeneic transplantation in children, Bone Marrow Transplant., 24, 583, 10.1038/sj.bmt.1701961 Schumm, 1999, Isolation of highly purified autologous and allogeneic peripheral CD34(+) cells using the CliniMACS device, J. Hematother., 8, 209, 10.1089/106161299320488 Bader, 1997, Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children, Bone Marrow Transplant., 19, 697, 10.1038/sj.bmt.1700721 Lang, 2003, Transplantation of highly purified CD34(+) progenitor cells from unrelated donors in pediatric leukemia, Blood, 101, 1630, 10.1182/blood-2002-04-1203 Barfield, 2004, A one-step large-scale method for T- and B-cell depletion of mobilized PBSC for allogeneic transplantation, Cytotherapy, 6, 1, 10.1080/14653240310004411 Lang, 2004, Use of CD3+/CD19+ depleted grafts from mismatched related donors in children, Bone Marrow Transplant., 33, S94 Borgmann, 2003, Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis, Blood, 101, 3835, 10.1182/blood.V101.10.3835 Bunin, 2002, Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission, Blood, 99, 3151, 10.1182/blood.V99.9.3151 Locatelli, 2002, Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors, Leukemia, 16, 2228, 10.1038/sj.leu.2402690 Sierra, 2000, Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience, Bone Marrow Transplant., 26, 397, 10.1038/sj.bmt.1702519 Woolfrey, 1998, Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome, Blood, 92, 3546, 10.1182/blood.V92.10.3546 Locatelli, 1996, Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry, Bone Marrow Transplant., 18, 63 Feuchtinger, 2004, Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy, Exp. Hematol., 32, 282, 10.1016/j.exphem.2003.12.009 Zeis, 1997, Allogeneic MHC-mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukaemia effect in mice, Br. J. Haematol., 96, 757, 10.1046/j.1365-2141.1997.d01-2101.x Ruggeri, 2002, Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants, Science, 295, 2097, 10.1126/science.1068440 Lang, 2000, Antileukemic activity and risk of relapse after allogeneic transplantation of purified peripheral CD34+ stem cells in children, Blood, 96, S582 Lang, 2004, Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts, Blood, 103, 3982, 10.1182/blood-2003-05-1735 Leung, 2004, Determinants of antileukemia effects of allogeneic NK cells, J. Immunol., 172, 644, 10.4049/jimmunol.172.1.644